Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML.

Source:http://linkedlifedata.com/resource/pubmed/id/19144991

Blood 2009 Apr 23 113 17 4052-62

Download in:

View as

General Info

PMID
19144991